Live from the NIH registry
Studies recruiting near Shreveport right now
Top 25 of 170 recruiting studies, sorted by proximity — each links to its official registry page
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
Spine Institute of Louisiana — Shreveport, Louisiana (4.9 mi)
· Sponsor: International Spine Study Group Foundation
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Trials365 LLC — Shreveport, Louisiana (4.9 mi)
· Sponsor: Daiichi Sankyo
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Willis-Knighton Cancer and Proton Therapy Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Proton Collaborative Group
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Overton Brooks V.A. Medical Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Novo Nordisk A/S
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Akero Therapeutics, Inc
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Louisiana Research Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Eli Lilly and Company
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Louisiana State University Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Mercy Health Ohio
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Louisiana State University Health Sciences Shreveport ( Site 0029) — Shreveport, Louisiana (4.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Kailera
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: AstraZeneca
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sickle Cell Disease
Phase 3
Interventional 192 participants sought
Louisiana State University Health Sciences Center - Shreveport- Site Number : 8400037 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Sanofi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Grace Research, LLC-Shreveport-64616 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Boehringer Ingelheim
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Shreveport, Louisiana (4.9 mi)
· Sponsor: Medtronic
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: SWOG Cancer Research Network
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
LSU Health Sciences Center — Shreveport, Louisiana (4.9 mi)
· Sponsor: Jazz Pharmaceuticals
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Sleep Apnea, Obstructive, Obesity
Phase 3
Interventional 800 participants sought
Care Access - Shreveport 2 — Shreveport, Louisiana (4.9 mi)
· Sponsor: Eli Lilly and Company
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Adjustment Disorder
Phase 2
Interventional 100 participants sought
LSU Health Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Reunion Neuroscience Inc
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Shreveport, Louisiana (4.9 mi)
· Sponsor: GlaxoSmithKline
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: Wake Forest University Health Sciences
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
LSU Health Shreveport Clinical Trials Office — Shreveport, Louisiana (4.9 mi)
· Sponsor: Pfizer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
LSU Health Sciences Center at Shreveport — Shreveport, Louisiana (4.9 mi)
· Sponsor: National Cancer Institute (NCI)